Dr.ย Shukuiย Qin
MD, PhD
Chief Physician, Professor and PhD Supervisor in Medical Oncology
corporate_fareNanjing Tianyinshan Hospital, China Pharmaceutical University, Nanjing
Shukui Qin
MD, PhD
Prof. Shukui Qin is one of China's leading medical oncologists, recognised for his work in liver cancer, biliary tract cancer, pancreatic cancer and other gastrointestinal malignancies. He combines frontline patient care with clinical research and the development of national treatment guidelines.
Prof. Qin has particular expertise in the systemic treatment of hepatocellular carcinoma, including targeted therapies, immunotherapy-based combinations and multidisciplinary strategies for patients with advanced or difficult-to-treat disease. He has led or participated in more than 350 international and domestic clinical trials of anticancer medicines and has served as leading principal investigator for more than 200 national and international studies. His research has appeared in major journals including The Lancet, The New England Journal of Medicine, JAMA and the Journal of Clinical Oncology. He currently serves as Honorary President and Chief Expert of Nanjing Tianyinshan Hospital of China Pharmaceutical University and Honorary President of Shanghai GoBroad Cancer Hospital.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Qin, subject to hospital availability and case acceptance.
Why Consider Prof. Shukui Qin?
Prof. Qin is one of China's most influential medical oncologists in liver and gastrointestinal cancer, with deep experience in advanced and difficult-to-treat disease.
Areas of Specialization
Systemic treatment of liver, biliary and gastrointestinal cancers
Prof. Qin focuses on medical (systemic) treatment of hepatobiliary and gastrointestinal cancers, with strategies tailored to cancer type, disease stage, prior therapies, liver function and molecular characteristics.
Hepatobiliary Cancer
Systemic and multidisciplinary management of liver and biliary tract cancers.
- arrow_rightFirst-line and later-line systemic therapy for advanced liver cancer
- arrow_rightImmunotherapy-based combinations and targeted agents
- arrow_rightTreatment after progression on prior targeted therapy or immunotherapy
- arrow_rightCholangiocarcinoma systemic treatment planning
- arrow_rightGallbladder cancer management
- arrow_rightImmunotherapy plus chemotherapy combinations where suitable
Gastrointestinal Cancer
Medical oncology for digestive-system cancers, including advanced and refractory cases.
- arrow_rightSystemic therapy for advanced and difficult-to-treat gastric cancer
- arrow_rightTreatment planning for colorectal cancer
- arrow_rightBiomarker-guided treatment selection where applicable
- arrow_rightMultidisciplinary systemic treatment planning
- arrow_rightAssessment of suitable clinical trial options
Immunotherapy & Targeted Therapy
Advanced systemic approaches for selected solid tumours.
- arrow_rightPD-1 / PD-L1 inhibitor-based combinations for suitable patients
- arrow_rightTreatment planning based on pathology and clinical assessment
- arrow_rightAnti-angiogenic and molecularly guided treatment
- arrow_rightBiomarker-driven treatment selection where applicable
Procedures Performed
Clinical services and treatment approaches
As a medical oncologist, Prof. Qin focuses on systemic cancer treatment, molecular-guided therapy selection, multidisciplinary planning and expert second opinions for complex liver and gastrointestinal cancers.
Systemic Cancer Treatment
Medical OncologyPlanning and administration of systemic therapy for liver, biliary and gastrointestinal cancers.
Targeted & Immunotherapy Planning
Targeted TherapySelection of targeted agents and immunotherapy combinations for advanced solid tumours.
Diagnostic & Staging Review
DiagnosisAssessment of pathology, imaging and liver function to guide treatment.
Multidisciplinary Treatment Planning
MultidisciplinaryCoordination of systemic and locoregional treatment within a multidisciplinary team.
Second Opinion Consultations
Second OpinionIndependent expert review of diagnosis and treatment options for liver and GI cancers.
Research & Publications
Clinical trial leadership and peer-reviewed contributions
Prof. Qin has played a central role in clinical research on new systemic treatments for liver and gastrointestinal cancers, contributing to the development and regulatory approval of several anticancer medicines.
Prof. Qin's extensive trial experience means eligible patients may be assessed for novel therapies. CancerFax can help review eligibility and coordinate next steps, subject to hospital availability.
Education & Training
Prof. Qin trained in China and undertook advanced academic training in the United States.
Clinical Experience
Prof. Qin has more than three decades of experience in clinical oncology, liver cancer research and anticancer drug development in China.
Languages & International
Prof. Qin consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support when required.
How CancerFax Helps You Access Dr. Shukui Qin
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Shukui Qin's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Shukui Qin's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Shukui Qin before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Shukui Qin's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Shukui Qin's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Shukui Qin's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Shukui Qin
Prof. Qin specialises in liver cancer (hepatocellular carcinoma), biliary tract cancer, gallbladder cancer, pancreatic cancer, gastric cancer and colorectal cancer. He focuses on systemic treatment, including immunotherapy and targeted therapy, for advanced and difficult-to-treat disease.
Yes. Hepatocellular carcinoma is one of his principal areas of expertise. He was the lead author of the CARES-310 Phase III trial and the national leading principal investigator in China for several major liver cancer studies involving targeted therapy and immunotherapy.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Qin, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the hospital or doctor, subject to availability.
Yes. A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history and relevant test results. The final consultation format and availability depend on the doctor's institution.
Yes. He has led or participated in more than 350 anticancer drug trials and has served as leading principal investigator for more than 200 studies. Where relevant, CancerFax can help assess eligibility for suitable clinical trial options.
Connect with Shukui Qin Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.